49%
Finnrick rating
#1 of 54 CJC-1295 vendors
5 of 7 classifiable tests passed
natural 71% · customers 4.9★ (5)
methodology · Purity focus
Finnrick analysis · CJC-1295

Yimei's CJC-1295 rating is held back by mixed purity evidence: an 89.3% result and a later 99.4% miss interrupt otherwise clean identity results. Check the +30% fill pass and repeated lack of batch identifiers.

methodology →
vendor intelligence report
Vendor Intelligence Report: Yimei

Corporate records tie the Yimei-named UK layer to a dissolved company while Pepturion’s UK-facing site omits ordinary legal identifiers. The report maps the rebrand trail, Hong Kong contact signal, China-side supplier records, payment recourse gaps, and promo-code network.

26 pages6 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.10
96%
15
2
Ipamorelin
$1.14
85%
8
3
Retatrutide
$1.28
84%
51
4
Tirzepatide
$0.56
81%
7
5
BPC-157
$1.42
63%
11
6
Tesamorelin
$3.69
55%
6
7
CJC-1295selected
$2.58
49%
7
8
TB-500
$3.03
42%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%20 Feb 2026: 30%26 Feb 2026: 37%4 Mar 2026: 44%6 Mar 2026: 51%18 Mar 2026: 49%28 Apr 2026: 45%30 Apr 2026: 50%9 Aug 2026: current 49%30%45%49%Feb 26Aug 26
Showing CJC-1295 tests only
Yimei CJC-1295 test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
30 Apr 2026Pass
Tested
lab nameView COA
28 Apr 2026Fail
Tested
lab nameView COA
18 Mar 2026Fail
Tested
lab nameView COA
6 Mar 2026Pass
Tested
lab nameView COA
4 Mar 2026Pass
Tested
lab nameView COA
26 Feb 2026Pass
Tested
lab nameView COA
20 Feb 2026Pass
Tested
lab nameView COA

About Yimei test results from Finnrick

Yimei is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 110 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Yimei peptides in this dataset are CJC-1295 (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 110 recent tests.

Corrections
No corrections.